{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-016520","form_type":"8-K","ticker":null,"cik":"0001865127","company_name":"Lucy Scientific Discovery, Inc.","filed_at":"2024-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.140671+00:00","generated_at":"2026-06-05T17:32:28.225476+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Nasdaq warns Lucy Scientific of potential delisting due to equity below $2.5M","bullets":["Stockholders' equity as of Dec 31, 2023 was ~$81,158 vs $2.5M minimum required.","Company has 45 days to submit compliance plan; if accepted, extension to Aug 14, 2024.","Also facing bid price non-compliance; 1-for-10 reverse stock split effective Feb 26, 2024.","No immediate delisting, but failure could result in trading on OTC Markets."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-016520","json":"https://secwatch.observer/filing/0001213900-24-016520.json","markdown":"https://secwatch.observer/filing/0001213900-24-016520.md","text":"https://secwatch.observer/filing/0001213900-24-016520.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1865127/000121390024016520/0001213900-24-016520-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1865127/000121390024016520/ea0200521-8k_lucyscien.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T17:32:28.225476+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f1c340eceed5cc4c2d98f772e47296d9d9ce5191","claim":"Lucy Scientific Discovery, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"$2.5 million (the “ Minimum Stockholders’ Equity Requirement ”). As reported in its Form 10-Q, the Company’s stockholders’ equity as of December 31, 2023, was approximately $81,158. In addition, the Company did not meet the alternatives of market value of listed securities or net income from continuing operations as of the date of the Letter. In accordance","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1865127/000121390024016520/0001213900-24-016520-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}